Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Dishi Medical Biotechnology is developing a portfolio of medical devices focused primarily on ophthalmic surgery robots and related instruments. Their pipeline consists of three products in early development stages targeting ophthalmic diseases and general surgery device markets. No clinical results are available as the products are still in early-stage development[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Dishi Medical Biotechnology.